share_log

藥明康德：翌日披露報表

WUXI APPTEC: Next Day Disclosure Return

香港交易所 ·  Apr 8 17:05
Summary by Futu AI
無錫藥明康德新藥開發股份有限公司（药明康德）於2024年3月11日至4月8日期間，通過上海證券交易所回購共計7,319,317股A股股份。該公司股份回購行動始於2024年3月11日，首次回購937,079股，並於4月8日回購434,846股作為最後一次交易，每股回購價格介於RMB 45.78至RMB 57.32之間。根據香港聯合交易所有限公司證券上市規則，公司於4月8日向香港聯交所提交翌日披露報表，披露已發行股本變動情況。該系列股份回購未涉及股份註銷，並由公司董事李革正式呈交。
無錫藥明康德新藥開發股份有限公司（药明康德）於2024年3月11日至4月8日期間，通過上海證券交易所回購共計7,319,317股A股股份。該公司股份回購行動始於2024年3月11日，首次回購937,079股，並於4月8日回購434,846股作為最後一次交易，每股回購價格介於RMB 45.78至RMB 57.32之間。根據香港聯合交易所有限公司證券上市規則，公司於4月8日向香港聯交所提交翌日披露報表，披露已發行股本變動情況。該系列股份回購未涉及股份註銷，並由公司董事李革正式呈交。
Wuxi Pharmaceutical Ming Kand New Drug Development Co., Ltd. (Pharmaceutical Ming Kand) repurchased a total of 7,319,317 A-shares through the Shanghai Stock Exchange between March 11 and April 8, 2024. The Company's share repurchase operation began on March 11, 2024, with a first repurchase of 937,079 shares and a final repurchase of 434,846 shares on April 8, with a repurchase price of RMB 45.78 to RMB 57.32 per share. Pursuant to the Listing Rules of the Stock Exchange of Hong Kong Limited, the Company filed a next-day disclosure statement with the Stock Exchange on 8 April, disclosing the changes in issued share capital. The share repurchase of the series did not involve a share write-off and was formally presented by Mr. Li Keung, the Company's director.
Wuxi Pharmaceutical Ming Kand New Drug Development Co., Ltd. (Pharmaceutical Ming Kand) repurchased a total of 7,319,317 A-shares through the Shanghai Stock Exchange between March 11 and April 8, 2024. The Company's share repurchase operation began on March 11, 2024, with a first repurchase of 937,079 shares and a final repurchase of 434,846 shares on April 8, with a repurchase price of RMB 45.78 to RMB 57.32 per share. Pursuant to the Listing Rules of the Stock Exchange of Hong Kong Limited, the Company filed a next-day disclosure statement with the Stock Exchange on 8 April, disclosing the changes in issued share capital. The share repurchase of the series did not involve a share write-off and was formally presented by Mr. Li Keung, the Company's director.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.